Attitudes to Prophylactic Surgery and Chemoprevention in Australian Women at Increased Risk for Breast Cancer
Overview
Affiliations
Background: Because of the uncertain efficacy of breast cancer screening in women at increased risk of developing breast cancer, bilateral prophylactic oophorectomy and mastectomy are considered management options for high-risk women. Data on the attitudes to prophylactic strategies of high-risk women who have not attended specialist clinics are needed to ascertain the need for patient education and provide the basis for planning of support services.
Methods: Three hundred seventy-one women unaffected by cancer and with unknown mutation status from families with a dominantly inherited susceptibility to breast cancer, recruited through a large Australian population-based, epidemiological study, were assessed using a mailed self-administered questionnaire with validated measures of psychological outcome.
Results: Sixteen percent of women reported considering prophylactic mastectomy, and 1% had already had the procedure. Among women with a family history of breast/ovarian cancer, 33% had considered and 5% had already had a prophylactic oophorectomy. Twenty-three percent of women reported considering taking tamoxifen if it were shown to prevent breast cancer. Consideration of prophylactic oophorectomy (OR = 1.51 for a 10% change in perceived risk, 95% CI 1.14-1.99, p = 0.0045) and tamoxifen (OR = 1.14 for a 10% change in perceived risk, 95% CI 1.002-1.30, p = 0.047) were positively associated with perceived cancer risk.
Conclusions: Attitudes to prophylactic surgery and psychological distress levels in high-risk women participating in an epidemiological study appear to be comparable to those of women attending familial cancer clinics and indicate that women attending high-risk clinics may be representative of the larger population of women at increased risk.
Current and Emerging Strategies for Tubo-Ovarian Cancer Diagnostics.
Brincat M, Mira A, Lawrence A Diagnostics (Basel). 2023; 13(21).
PMID: 37958227 PMC: 10647517. DOI: 10.3390/diagnostics13213331.
Archer S, Fennell N, Colvin E, Laquindanum R, Mills M, Dennis R Cancers (Basel). 2022; 14(11).
PMID: 35681696 PMC: 9179465. DOI: 10.3390/cancers14112716.
Meiser B, Wong W, Peate M, Julian-Reynier C, Kirk J, Mitchell G Hered Cancer Clin Pract. 2017; 15:14.
PMID: 28943990 PMC: 5607482. DOI: 10.1186/s13053-017-0075-8.
Decision making for breast cancer prevention among women at elevated risk.
Padamsee T, Wills C, Yee L, Paskett E Breast Cancer Res. 2017; 19(1):34.
PMID: 28340626 PMC: 5366153. DOI: 10.1186/s13058-017-0826-5.
Stabile C, Gunn A, Sonoda Y, Carter J Transl Androl Urol. 2016; 4(2):169-85.
PMID: 26816823 PMC: 4708131. DOI: 10.3978/j.issn.2223-4683.2015.04.03.